Skip to content

Circles

A

aTYR PHARMA INC

ATYR· Nasdaq

A

ATYRaTYR PHARMA INC

ATYRaTYR PHARMA INC·Earnings record

Q1 2014

Source filing unavailable

Next · Q2 2014

Q1 2014 · —

Revenue—

Net Income

-$6.09M

no prior Q1 2013 on file

EPS Diluted

-$7.87

no prior Q1 2013 on file

Operating Income-$5,930,000—

Operating Cash Flow-$6,345,000—

Free Cash Flowderived-$6,556,000—

Same quarter

no prior Q1 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’14Q2 ’14 Q3 ’14 Q4 ’14 Q1 ’15 Q2 ’15 Q3 ’15 Q4 ’15 Q1 ’16…

aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Movers Indexes IPOs Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Changelog Circles Account Terms Privacy